Panels of genetic tests, genetic predispositions
The PREGMED Non Public Clinic collaborates with
the Genetic Laboratory, which is a part of the INVICTA Medical Laboratories (since 2001) and is a leader in complex DNA analyses. With its many-year experience, acquired both in Poland and at international centres, modern technologies and an innovative quality control system, it offers tests at very high sensitivity and reliability levels An emphasis on top quality and reliability of results is the key standard of the INVICTA Laboratories.
The INVICTA Genetic Laboratory offers a broad range of molecular biology studies, including:
- tests for predisposition to thromboembolic diseases
- tests for predispositions to diseases of internal organs (kidneys, colon, stomach, lungs, ovaries, breasts, the prostate gland)
- diagnostics towards genetically determined male and female infertility
- genetic diagnostics of genitourinary tract infections
- diagnostics of bacterial and viral infections plus many others.
The quality and reliability of tests, carried out at the INVICTA Laboratory, are confirmed by Polish and international certificates. The Laboratory’s activity is subject of regular, cyclic audits, while the knowledge and skills of its staff are verified by independent experts on current basis..
INVICTA’s patients obtain also an easy and quick access to test results and Rother important data via the INVICTA-ONLINE system.
Based on our collaboration with the INVICTA Genetic Laboratory, we offer state-of-the-art. genetic tests for genetic predispositions. The tests are carried out on collected saliva samples, thus they are non-invasive and painless.
Test results are completed with risk assessment, prophylactic recommendations and practical indications, regarding appropriate style of life. The approximate waiting time for test results is 14 days.
See the table below for a list of proposed panels of genetic tests
|
Panel name |
Tests in panel |
Description |
Type of material |
Price (PLN) |
|
Contraception |
Detection of G20210A mutations in prothrombin gene (blood coagulation factor II) |
Predispositions to thromboembolic diseases, induced by hormonal contraception |
saliva |
400 |
|
Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V) |
||||
|
Detection of polymorphism in MTHFR gene |
||||
|
Detection of mutations in BRCA-1 gene |
||||
|
Genetic |
Detection of deletion in the AZF region |
Predispositions to diseases and neoplasms |
saliva |
900 |
|
Detection of G20210A mutations in prothrombin gene (blood coagulation factor II) |
||||
|
Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V) |
||||
|
Detection of 2 mutations in CFTR gene |
||||
|
Detection of mutations in BRCA-1 gene |
||||
|
Detection of polymorphism in MTHFR gene |
||||
|
Detection of polymorphism in ACE gene |
||||
|
Detection of mutations in NOD2 gene |
||||
|
Detection of mutations in CHEK2 gene |
||||
|
Hormones |
Detection of G20210A mutations in prothrombin gene (blood coagulation factor II) |
Predispositions to thromboembolic diseases |
saliva |
400 |
|
Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V) |
||||
|
Detection of polymorphism in MTHFR gene |
||||
|
Detection of mutations in BRCA-1 gene |
||||
|
Male infertility |
Detection of deletion in the AZF region |
Underlying genetic defects of male infertility |
saliva |
200 |
|
Detection of 2 mutations in CFTR gene |
||||
|
Female infertility |
Detection of G20210A mutations in prothrombin gene (blood coagulation factor II) |
Underlying genetic defects of female infertility |
saliva |
400 |
|
Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V) |
||||
|
Detection of polymorphism in MTHFR gene |
||||
|
Detection of 2 mutations in CFTR gene |
||||
|
Neoplasms |
Detection of mutations in BRCA-1 gene |
Predispositions to neoplasms |
saliva |
300 |
|
Detection of mutations in NOD2 gene |
||||
|
Detection of mutations in CHEK2 gene |
||||
|
Breast and ovarian cancer |
Detection of mutations w genie BRCA-1 |
Predispositions to breast and ovarian cancer |
saliva |
300 |
|
Detection of mutations in NOD2 gene |
||||
|
Detection of mutations in CHEK2 gene |
||||
|
Spontaneous abortions |
Detection of G20210A mutations in prothrombin gene (blood coagulation factor II) |
Predispositions to spontaneous abortions |
saliva |
300 |
|
Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V) |
||||
|
Detection of polymorphism in MTHFR gene |
||||
|
The heart |
Detection of G20210A mutations in prothrombin gene (blood coagulation factor II) |
Predispositions to thromboembolic diseases |
saliva |
300 |
|
Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V) |
||||
|
Detection of polymorphism in MTHFR gene |
||||
|
The heart and hypertension |
Detection of G20210A mutations in prothrombin gene (blood coagulation factor II) |
Predispositions to thromboembolic diseases and hypertension |
saliva |
400 |
|
Detection of Leiden mutations in proaccelerin gene (blood coagulation factor V) |
||||
|
Detection of polymorphism in MTHFR gene |
||||
|
Detection of polymorphism in ACE gene |
Check our offer